Madison Avenue Partners, LP - Q3 2023 holdings

$705 Million is the total value of Madison Avenue Partners, LP's 20 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 47.4% .

 Value Shares↓ Weighting
NewSHARKNINJA INC$283,361,1756,112,191
+100.0%
40.21%
GHC BuyGRAHAM HLDGS CO$122,080,783
+6.6%
209,401
+4.4%
17.32%
-30.7%
GIII SellG III APPAREL GROUP LTD$79,469,805
+5.3%
3,188,997
-18.5%
11.28%
-31.5%
TBPH  THERAVANCE BIOPHARMA INC$60,515,510
-16.6%
7,012,2260.0%8.59%
-45.8%
IART BuyINTEGRA LIFESCIENCES HLDS C$36,840,633
-3.1%
964,667
+4.3%
5.23%
-37.0%
 STAGWELL INC$33,522,535
-35.0%
7,147,6620.0%4.76%
-57.7%
PFSW  PFSWEB INC$19,590,926
+64.6%
2,633,1890.0%2.78%
+7.0%
SellORION GROUP HLDGS INC$18,241,674
-32.6%
3,501,281
-14.5%
2.59%
-56.2%
OVID BuyOVID THERAPEUTICS INC$14,010,275
+29.1%
3,648,509
+10.3%
1.99%
-16.0%
MACK  MERRIMACK PHARMACEUTICALS INC$6,819,538
+0.2%
553,0850.0%0.97%
-34.8%
FSP BuyFRANKLIN STR PPTYS CORP$6,089,170
+109.7%
3,291,443
+64.4%
0.86%
+36.3%
New2SEVENTY BIO INC$5,856,9701,494,125
+100.0%
0.83%
GOSS NewGOSSAMER BIO INC$5,105,2876,130,268
+100.0%
0.72%
SELB NewSELECTA BIOSCIENCES INC$4,248,5004,008,019
+100.0%
0.60%
MBI  MBIA INC$3,034,155
-16.6%
420,8260.0%0.43%
-45.6%
NewVESTIS CORPORATION$2,123,000110,000
+100.0%
0.30%
CEE  CENTRAL & EASTERN EUROPE FD$1,814,858
-5.1%
211,0300.0%0.26%
-38.1%
BuyINDIVIOR PLCord$901,737
+238.3%
39,087
+249.0%
0.13%
+120.7%
LNSR SellLENSAR INC$742,654
-51.1%
240,341
-32.8%
0.10%
-68.3%
SFE SellSAFEGUARD SCIENTIFICS INC$359,085
-44.4%
359,085
-8.3%
0.05%
-63.8%
JRVR ExitJAMES RIV GROUP LTD$0-63,887
-100.0%
-0.26%
ExitSYLVAMO CORP$0-40,163
-100.0%
-0.35%
ExitMASTERBRAND INC$0-1,298,688
-100.0%
-3.30%
FHN ExitFIRST HORIZON CORPORATION$0-1,843,065
-100.0%
-4.53%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GRAHAM HLDGS CO15Q3 202325.7%
SUPER MICRO COMPUTER INC13Q1 202324.2%
LENSAR INC12Q3 20231.7%
PG&E CORP10Q2 20227.5%
SAFEGUARD SCIENTIFICS INC10Q3 20231.9%
THERAVANCE BIOPHARMA INC9Q3 202316.4%
ADTALEM GLOBAL ED INC9Q1 202217.5%
STAGWELL INC9Q3 202311.4%
JAMES RIV GROUP LTD9Q2 202317.6%
PFSWEB INC9Q3 20236.3%

View Madison Avenue Partners, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Madison Avenue Partners, LP Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
PFSWEB INCFebruary 14, 20232,633,18911.6%
Theravance Biopharma, Inc.February 14, 20237,012,22610.4%
James River Group Holdings, Ltd.February 14, 2022794,8372.1%
Sylvamo CorpFebruary 14, 20222,090,3354.7%
LEAF GROUP LTD.May 27, 20211,767,1934.9%
MDC PARTNERS INCFebruary 16, 20213,871,4345.3%
LENSAR, Inc.February 12, 2021637,2086.0%
SUPERIOR ENERGY SERVICES INCFebruary 14, 2020793,8585.4%

View Madison Avenue Partners, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-16
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-01-22
SC 13G/A2023-12-11
13F-HR2023-11-14
13F-HR2023-08-14
SC 13G2023-07-31
13F-HR2023-05-15

View Madison Avenue Partners, LP's complete filings history.

Compare quarters

Export Madison Avenue Partners, LP's holdings